Pinsent Masons hires Life Science partner in Dublin

11 Sep 2023 | 09:40 am | 1 min. read

Multinational law firm Pinsent Masons has hired transactional life sciences specialist Michael Stewart as partner in its Dublin office as it expands its pan-European Technology, Science and Industry (TSI) capabilities.

Michael is a leading life sciences lawyer, specialising in corporate transactional projects including M&A, assets sales and purchases, corporate finance and licensing and collaboration deals. 

Joining from Novartis, where he was most recently Lead Counsel in the group transactions team, Michael previously held roles as Global Head of Legal Strategic Transactions & Established Medicines in the company’s pharmaceuticals division and senior counsel in the Group M&A team. 

Michael is the fifth partner to join the firm’s TSI sector this year following IP life sciences expert Kristina Cornish, data and information law partner Jaya Handa, TMT cyber specialist Eleanor Ludlam and patent litigator James Marshall

Head of IP and Life Sciences at Pinsent Masons, Clare Tunstall, said: “Michael has acted on some of the biggest transactions in the sector. His in-house and private practice expertise will have a significant impact on our multinational life sciences capabilities and in particular will enhance our on the ground sector offering in Dublin. 

“High growth biotech and medtech start-ups play a pivotal role in the pharmaceuticals industry and we are confident that Michael’s expertise will enable us to further tap into this vibrant market.”

During his time at Novartis, Michael worked on major transactions including the spin-off by Novartis of Alcon (its eye care division), the acquisition by Sandoz of the Japan based generics business of Aspen Pharmacare Holdings and most recently, the announced sale by Novartis of Xiidra (a product for the treatment of dry eye disease) to Bausch + Lomb.

Commenting on his move Michael said: “After seven years in-house I am very excited to move back to private practice and continue my career at Pinsent Masons. The firm’s reputation as a leader in life sciences legal services, its stellar client base and depth of expertise will be an excellent platform that will enable me to build a thriving cross border practice.”

Latest press releases

Show me all press releases

Pinsent Masons appointed by HEINEKEN UK as its principal legal supplier

Multinational law firm Pinsent Masons has been named by HEINEKEN UK as its principal legal provider.

Pinsent Masons advises Clarios on Series B1 financing round of Altris

Multinational law firm Pinsent Masons advised Clarios on its investment in Altris as part of the Series B1 financing round.

Pinsent Masons continues expansion in Australia with two senior corporate appointments

Multinational law firm Pinsent Masons has continued its expansion in Australia with the appointment of partner James Stewart and special counsel Roger Hawkins to our corporate team.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Clarios on Series B1 financing round of Altris

Multinational law firm Pinsent Masons advised Clarios on its investment in Altris as part of the Series B1 financing round.

Pinsent Masons continues expansion in Australia with two senior corporate appointments

Multinational law firm Pinsent Masons has continued its expansion in Australia with the appointment of partner James Stewart and special counsel Roger Hawkins to our corporate team.

Pinsent Masons advises Skillko on sale to HSI

Multinational law firm Pinsent Masons through its Dublin office Pinsent Masons Ireland LLP has advised the founders of Skillko, Dermot O’Connor and Brendan Moloney, on its sale to US buyer HSI.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.